Rimonabant Acomplia

Rimonabant Helps With Weight Loss Rimonabant is an anorectic anti obesity drug. ...

Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity Under development by Sanofi-Aventis, Acomplia (rimonabant) is a selective CB1 endocannabinoid receptor antagonist indicated for the treatment of obesity. Under development by Sanofi-Aventis, Acomplia (rimonabant) is a selective CB1 endocannabinoid receptor antagonist indicated for the treatment of obesity. "Acomplia is a selective ...